참고문헌
- Jaynes M, Kumar AB. The risks of long-term use of proton pump inhibitors: a critical review. Ther Adv Drug Saf 2019;10:1-13.
- Jones NL, Koletzko S, Goodman K, Bontems P, Cadranel S, Casswall T, et al.; ESPGHAN, NASPGHAN. Joint ESPGHAN/NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents (update 2016). J Pediatr Gastroenterol Nutr 2017;64:991-1003. https://doi.org/10.1097/MPG.0000000000001594
- Rosen R, Vandenplas Y, Singendonk M, Cabana M, DiLorenzo C, Gottrand F, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2018;66:516-54. https://doi.org/10.1097/MPG.0000000000001889
- Lucendo AJ, Molina-Infante J, Arias A, von Arnim U, Bredenoord AJ, Bussmann C, et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J 2017;5:335-8. https://doi.org/10.1177/2050640616689525
- Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional disorders: children and adolescents. Gastroenterology 2016;150:1456-68.e2. https://doi.org/10.1053/j.gastro.2016.02.015
- Gralnek IM, Dumonceau JM, Kuipers EJ, Lanas A, Sanders DS, Kurien M, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015;47:a1-46. https://doi.org/10.1055/s-0034-1389830
- Bell JC, Schneuer FJ, Harrison C, Trevena L, Hiscock H, Elshaug AG, et al. Acid suppressants for managing gastro-oesophageal reflux and gastro-oesophageal reflux disease in infants: a national survey. Arch Dis Child 2018;103:660-4. https://doi.org/10.1136/archdischild-2017-314161
- Ruigomez A, Hungin AP, Lundborg P, Johansson S, Wallander MA, Garcia Rodriguez LA. Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 2011;23:232-7. https://doi.org/10.1097/MEG.0b013e328343b06e
- Barron JJ, Tan H, Spalding J, Bakst AW, Singer J. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr 2007;45:421-7. https://doi.org/10.1097/MPG.0b013e31812e0149
- De Bruyne P, Ito S. Toxicity of long-term use of proton pump inhibitors in children. Arch Dis Child 2018;103:78-82. https://doi.org/10.1136/archdischild-2017-314026
- Imhann F, Bonder MJ, Vich Vila A, Fu J, Mujagic Z, Vork L, et al. Proton pump inhibitors affect the gut microbiome. Gut 2016;65:740-8. https://doi.org/10.1136/gutjnl-2015-310376
- Rosen R, Amirault J, Liu H, Mitchell P, Hu L, Khatwa U, et al. Changes in gastric and lung microflora with acid suppression: acid suppression and bacterial growth. JAMA Pediatr 2014;168:932-7. https://doi.org/10.1001/jamapediatrics.2014.696
- Bruno G, Zaccari P, Rocco G, Scalese G, Panetta C, Porowska B, et al. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World J Gastroenterol 2019;25:2706-19. https://doi.org/10.3748/wjg.v25.i22.2706
- Mishiro T, Oka K, Kuroki Y, Takahashi M, Tatsumi K, Saitoh T, et al. Oral microbiome alterations of healthy volunteers with proton pump inhibitor. J Gastroenterol Hepatol 2018;33:1059-66. https://doi.org/10.1111/jgh.14040
- Belei O, Olariu L, Dobrescu A, Marcovici T, Marginean O. Is it useful to administer probiotics together with proton pump inhibitors in children with gastroesophageal reflux? J Neurogastroenterol Motil 2018;24:51-7. https://doi.org/10.5056/jnm17059
- Surendran Nair M, Amalaradjou MA, Venkitanarayanan K. Antivirulence properties of probiotics in combating microbial pathogenesis. Adv Appl Microbiol 2017;98:1-29. https://doi.org/10.1016/bs.aambs.2016.12.001
- Scott AM, Clark J, Julien B, Islam F, Roos K, Grimwood K, et al. Probiotics for preventing acute otitis media in children. Cochrane Database Syst Rev 2019;6:CD012941.
- Laursen RP, Hojsak I. Probiotics for respiratory tract infections in children attending day care centers-a systematic review. Eur J Pediatr 2018;177:979-94. https://doi.org/10.1007/s00431-018-3167-1
- Urbanska M, Gieruszczak-Bialek D, Szajewska H. Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for diarrhoeal diseases in children. Aliment Pharmacol Ther 2016;43:1025-34. https://doi.org/10.1111/apt.13590
- Hojsak I, Szajewska H, Canani RB, Guarino A, Indrio F, Kolacek S, et al.; ESPGHAN Working Group for Probiotics/Prebiotics. Probiotics for the prevention of nosocomial diarrhea in children. J Pediatr Gastroenterol Nutr 2018;66:3-9. https://doi.org/10.1097/MPG.0000000000001637
- Szajewska H, Canani RB, Guarino A, Hojsak I, Indrio F, Kolacek S, et al.; ESPGHAN Working Group for ProbioticsPrebiotics. Probiotics for the prevention of antibiotic-associated diarrhea in children. J Pediatr Gastroenterol Nutr 2016;62:495-506. https://doi.org/10.1097/MPG.0000000000001081
- Szajewska H, Guarino A, Hojsak I, Indrio F, Kolacek S, Shamir R, et al.; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr 2014;58:531-9. https://doi.org/10.1097/MPG.0000000000000320
- Sindhu KN, Sowmyanarayanan TV, Paul A, Babji S, Ajjampur SS, Priyadarshini S, et al. Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2014;58:1107-15. https://doi.org/10.1093/cid/ciu065
- Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 2006;117:e817-20. https://doi.org/10.1542/peds.2005-1655
- Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr 2009;154:514-20.e4. https://doi.org/10.1016/j.jpeds.2008.09.054
- Winter H, Kum-Nji P, Mahomedy SH, Kierkus J, Hinz M, Li H, et al. Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD. J Pediatr Gastroenterol Nutr 2010;50:609-18. https://doi.org/10.1097/MPG.0b013e3181c2bf41
- Writing Committee for the American Lung Association Asthma Clinical Research Centers, Holbrook JT, Wise RA, Gold BD, Blake K, Brown ED, et al. Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA 2012;307:373-81. https://doi.org/10.1001/jama.2011.2035
- Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, et al. COMPASS Investigators. Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin. Gastroenterology 2019;157:682-91.e2. https://doi.org/10.1053/j.gastro.2019.05.056